Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

A Novel Cyclic Squamosamide Analogue Compound FLZ Improves Memory Impairment in Artificial Senescence Mice Induced by Chronic Injection of D‐Galactose and NaNO2

View through CrossRef
Abstract:  The aim of the present study was to access the protective effect of a novel synthesized squamosamide cyclic analogue, compound FLZ, on memory impairment in artificially senescent mice induced by chronic injection of D‐galactose and sodium nitrite (NaNO2). Artificially senescent mouse model was induced by consecutive injection of D‐galactose (120 mg/kg) and NaNO2 (90 mg/kg) once daily for 60 days. Compound FLZ (75 and 150 mg/kg) was orally administered once daily for 30 days after D‐galactose and NaNO2 injection for 30 days. The water maze test was used to evaluate the learning and memory function of mice. The content of malondialdehyde (MDA) and the activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH‐Px) in serum were determined using different biochemical kits. The alterations in hippocampus morphology were assessed by light and electronic microscope. Immunoreactive cells of Bcl‐2 in the hippocampus were counted by immunohistochemical staining, and Bcl‐2 protein expression was analysed by Western blot method. The results indicate that injection of D‐galactose and NaNO2 induces memory impairment and neuronal damage in hippocampus of mice. In addition, serum SOD and GSH‐Px activities decreased, while MDA level increased. Bcl‐2‐positive neurons and Bcl‐2 protein expression in the hippocampus decreased remarkably. Oral administration of FLZ for 30 days significantly improved the cognitive deficits and the biochemical markers mentioned above, and also reduced the pathological alterations in mouse hippocampus. The results suggest that FLZ ameliorates memory deficits and pathological injury in artificially senescent mice induced by chronic injection of D‐galactose and NaNO2, indicating that FLZ is worth further studies for fighting antisenescence and dementia.
Title: A Novel Cyclic Squamosamide Analogue Compound FLZ Improves Memory Impairment in Artificial Senescence Mice Induced by Chronic Injection of D‐Galactose and NaNO2
Description:
Abstract:  The aim of the present study was to access the protective effect of a novel synthesized squamosamide cyclic analogue, compound FLZ, on memory impairment in artificially senescent mice induced by chronic injection of D‐galactose and sodium nitrite (NaNO2).
Artificially senescent mouse model was induced by consecutive injection of D‐galactose (120 mg/kg) and NaNO2 (90 mg/kg) once daily for 60 days.
Compound FLZ (75 and 150 mg/kg) was orally administered once daily for 30 days after D‐galactose and NaNO2 injection for 30 days.
The water maze test was used to evaluate the learning and memory function of mice.
The content of malondialdehyde (MDA) and the activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH‐Px) in serum were determined using different biochemical kits.
The alterations in hippocampus morphology were assessed by light and electronic microscope.
Immunoreactive cells of Bcl‐2 in the hippocampus were counted by immunohistochemical staining, and Bcl‐2 protein expression was analysed by Western blot method.
The results indicate that injection of D‐galactose and NaNO2 induces memory impairment and neuronal damage in hippocampus of mice.
In addition, serum SOD and GSH‐Px activities decreased, while MDA level increased.
Bcl‐2‐positive neurons and Bcl‐2 protein expression in the hippocampus decreased remarkably.
Oral administration of FLZ for 30 days significantly improved the cognitive deficits and the biochemical markers mentioned above, and also reduced the pathological alterations in mouse hippocampus.
The results suggest that FLZ ameliorates memory deficits and pathological injury in artificially senescent mice induced by chronic injection of D‐galactose and NaNO2, indicating that FLZ is worth further studies for fighting antisenescence and dementia.

Related Results

Study of the regulatory mechanism involved in dark-induced Postharvest leaf senescence
Study of the regulatory mechanism involved in dark-induced Postharvest leaf senescence
Postharvest leaf senescence contributes to quality losses in flowers and leafy vegetables. The general goal of this research project was to investigate the regulatory mechanisms in...
Squamosamide Derivative FLZ Diminishes Aberrant Mitochondrial Fission by Inhibiting Dynamin-Related Protein 1
Squamosamide Derivative FLZ Diminishes Aberrant Mitochondrial Fission by Inhibiting Dynamin-Related Protein 1
Mitochondrial dysfunction is involved in the pathogenesis of Parkinson’s disease (PD). Mitochondrial morphology is dynamic and precisely regulated by mitochondrial fission and fusi...
Abstract A16: Wnt antagonist SFRP1 functions as secreted mediator of senescence
Abstract A16: Wnt antagonist SFRP1 functions as secreted mediator of senescence
Abstract The purpose of this study was 1) to identify the mediator(s) of senescence that are secreted from senescent cells and induce senescence in an autocrine and ...
Squamosamide Derivative FLZ Protects Pancreaticβ-Cells from Glucotoxicity by Stimulating Akt-FOXO1 Pathway
Squamosamide Derivative FLZ Protects Pancreaticβ-Cells from Glucotoxicity by Stimulating Akt-FOXO1 Pathway
Chronic hyperglycemia increases apoptosis and reduces glucose-stimulated insulin secretion. Although protective agents have been searched extensively, none has been found so far. H...
Do cytochrome P450 2C9 pathways contribute to the cerebrovascular response to small muscle exercise?
Do cytochrome P450 2C9 pathways contribute to the cerebrovascular response to small muscle exercise?
Cytochrome P450 2C9 (CYP450) contributes to regulation of cerebral blood flow in animal models, however, the involvement of CYP450 in human cerebrovascular control is under researc...

Back to Top